Qlaris Bio is investigating a novel type of medicine to reduce the pressure inside the eye, with the hopes of providing a new and targeted option to people suffering from glaucoma. To help viewers understand how their investigational drug QLS-101 works, the first step was to make the complex anatomy of the eye more understandable and explain the variety of factors that regulate the pressure inside the eye under normal circumstances.
When Migraine Attacks
By
Michael Astrachan
Anyone who suffers from migraine can tell you it is more than just a bad …
Illustrating the Unconventional: PROTAC™ Technology for Disease Therapy
By
Michael Astrachan
XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional …
Can't Get Enough of XVIVO?
We’ve got you covered! Check out our latest wallpapers for stunning visuals!
Qlaris Bio is investigating a novel type of medicine to reduce the pressure inside the eye, with the hopes of providing a new and targeted option to people suffering from glaucoma. To help viewers understand how their investigational drug QLS-101 works, the first step was to make the complex anatomy of the eye more understandable and explain the variety of factors that regulate the pressure inside the eye under normal circumstances.
